NCT05185518View on ClinicalTrials.gov

Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

Use of novel insulin injection port

use subcutaneous port into which glucose monitor is embedded

Sponsors
All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

Pacific Diabetes Technologies

INDUSTRY